Several previous studies have suggested that neutrophilic airway inflammation in asthma may be effectively reduced by blocking NLRP3 inflammasome-mediated pyroptosis [10, 47, 48]; however, the results of clinical trials have been disappointing. Here, NLRP3 is linked to asthma.